FPT-SOFTWARE
2.11.2022 03:02:38 CET | Business Wire | Press release
Vietnam's leading IT services provider FPT Software, a member company of FPT Corporation, announced its new alliance with Julie Sandlau, one of the world's leading jewelry producers, supporting the company to build its first smart jewelry manufacturing factory in Vietnam. The partnership is expected to enhance FPT Software's presence in the Nordic region and incorporate digital technologies into Julie Sandlau's production line, revolutionizing it with Smart factories, Artificial Intelligence, Robotics, and so on.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221101005835/en/
FPT Software and Julie Sandlau signed the strategic partnership (Photo: Business Wire)
The signing ceremony took place on November 1st, in Hanoi, Vietnam, within the framework of Vietnam-Denmark Business Summit Forum 2022, organized by the Embassy of Denmark in Vietnam, Vietnamese Government Office and the Vietnamese Ministry of Foreign Affair in Denmark.
Through this alliance, FPT Software becomes Julie Sandlau’s strategic partner, provides the company with an exclusive roadmap to build their first Smart factory and transform the traditional jewelry manufacturing process with digital technologies like Robotic Process Automation, Artificial Intelligence, and more. The new manufacturing plant is set to be completed by the end of 2023 in Hoa Lac Hi-tech Park, Vietnam's first and largest hi-tech industrial zone.
The newly established partnership also transforms Julie Sandlau's operations and work processes, from human resources, operational management, to accounting and so on. FPT Software's automation and robotic processing solutions help ease the usual back-office procedures, reduce workload and workforce, thereby promoting and accompanying Julie Sandlau's towards sustainable development. The strategic step also allows Julie Sandlau's to expand its operations to a strategic market like Vietnam and target potential customers here.
FPT Corporation Chairman Dr Truong Gia Binh said. “In the past five decades, Vietnam and Denmark have established a strong relationship, with many deals among companies of both countries. With this partnership with Julie Sandlau, FPT believes that we can help reinforce the tight relationship between both nations.”
“As Vietnam’s leading IT solutions provider, FPT is confident to help Julie Sandlau with their digital transformation process and expansion goals in the Vietnamese and Southeast Asian markets”, Chairman Binh added.
“Vietnam always has a special place in our hearts since we started our business in 2006 here in Hanoi, so we are very excited to continue our Vietnam journey investing and developing further into digitalization, AI, blockchain technology and robotics.”, said Julie Sandlau’s CEO Soren Roed Pedersen.
“For years we have been first movers with our strong focus on ESG and we are now ready to start our digital transformation together with FPT and thus further proving the great collaboration between Vietnam and Denmark. We find the core values and vision of FPT and Julie Sandlau are a great match as we aim to transform a jewelry industry from traditional manufacturing methods to a modern digital hub. We have obviously great ambitions for our partnership with FPT as our long term strategy for Vietnam will develop into much more than just manufacturing.”, he further added.
"Julie Sandlau is our first-ever client in the jewelry manufacturing industry. This gives us more opportunities to explore and amplify FPT Software's technology potentials, especially in building a smart manufacturing factory for a client in a peculiar industry as such.”, FPT Software Europe CEO Hai Le said. "I believe this partnership will allow us to strengthen our workforce and experience, particularly in providing digital transformation solutions for future manufacturing clients.", he added.
On nurturing and developing human resources, FPT Software will transfer expertise and provide comprehensive training to Julie Sandlau's employees in Vietnam, with a deep dive into Artificial Intelligence applications. This practice will turn Julie Sandlau the world's first jewelry manufacturer to involve emerging technology in its production process, supporting its goal of becoming a digital transformation hero in premium accessories production by 2025.
The strategic partnership allows the two companies' employees to exchange knowledge and experiences, with Julie Sandlau offering fresh graduates from FPT University and FPT Corporation's staffs internship and employment opportunities. The program aims to improve educational quality and develop a guaranteed career path for future industrial engineers for FPT students and employees.
About FPT Software
FPT Software is a part of FPT Corporation, a globally leading technology and IT services & solutions provider headquartered in Vietnam with nearly US$1.6 billion in revenue and 41,000 employees in 27 countries. As a pioneer in digital transformation, it delivers world-class services in Smart factories, Digital platforms, RPA, AI, IoT, Enterprise Mobility, Digital Product Development, Cloud, AR/VR, Business Applications, Application Services, Managed Services, and so on. The company has served 1,000+ customers worldwide, nearly 100 of which are Fortune Global 500 companies in the industries of Aerospace & Aviation, Manufacturing & Automotive, Banking, Finance & Insurance, Logistics & Transportation, Healthcare & Life Sciences, Retail, Utilities & Energy, and more. For further information, please visit http://www.fpt-software.com.
About Julie Sandlau
Julie Sandlau Vietnam is the manufacturing arm of Danish luxury Jewelry brand Julie Sandlau and have since 2006 been producing high quality jewelry for some of the largest jewelry brands in the world with a strong focus on environment, sustainability and governance. The factory is committed to the United Nations Global Compact, The UN Women Empowerment Principles, The Science Based Target Initiative and is a certified member of the Responsible Jewellery Council, the highest international standard of responsible business practices in the jewelry business. With a workforce of nearly 400 people in which the goldsmiths are specialised and educated in Danish craftsmanship traditions and skills, Julie Sandlau Vietnam has been a first mover in CSR in Vietnam for years, winning multiple awards. All Julie Sandlau Vietnam's jewelry are made from recycled precious metals and sustainable certified gem stones giving their customers and stakeholders the ultimate trust and confidence in mutual business.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221101005835/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom